Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 7;5(3):otad043.
doi: 10.1093/crocol/otad043. eCollection 2023 Jul.

Integrating Intestinal Ultrasound into an Inflammatory Bowel Disease Practice: How to Get Started

Bincy P Abraham  1   2   3 , Dheeraj Reddy  4 , Adam Saleh  4
Affiliations

Integrating Intestinal Ultrasound into an Inflammatory Bowel Disease Practice: How to Get Started

Bincy P Abraham et al. Crohns Colitis 360. .

Abstract

Intestinal ultrasound (IUS) offers a safe, noninvasive, point-of-care tool for diagnosing and monitoring disease activity in patients with inflammatory bowel disease (IBD). IUS is used widely in Europe and Canada for IBD, but it remains underutilized in the United States. Growing interest in IUS in the United States has prompted many IBD centers to train their faculty in IUS. This, however, raises questions about how to effectively use this new tool in the United States, which does not use a social medicine model like those implemented in Europe and Canada. Here, we provide a practical framework for incorporating IUS in an IBD practice in the United States, including training requirements, equipment, and protocols for implementing IUS in daily practice.

Keywords: Crohn’s disease; Intestinal Ultrasound; inflammatory bowel disease; practice management; ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

Bincy P. Abraham: Consultant: Abbvie, Bristol Myers Squibb, Lilly, Fresenius Kabi, Janssen, Medtronic, Pfizer, Samsung bioepis, Takeda. Speaker’s Bureau: Abbvie, Bristol Myers Squibb, Janssen, Pfizer, Takeda, Lilly. Dheeraj Reddy: none. Adam Saleh: none.

Figures

Figure 1.
Figure 1.
Overall time to break even calculated by dividing the fixed costs by variable costs per month subtracted from revenue per month.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Turner D, Ricciuto A, Lewis A, et al. ; International Organization for the Study of IBD. STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology. 2021;160(5):1570-1583. doi: 10.1053/j.gastro.2020.12.031 - DOI - PubMed
    1. Saleh A, Abraham BP.. Utility of intestinal ultrasound in clinical decision-making for inflammatory bowel disease. Crohns Colitis 360. 2023;5(3):otad027. doi: 10.1093/crocol/otad027 - DOI - PMC - PubMed
    1. Sands BE. Biomarkers of inflammation in inflammatory bowel disease. Gastroenterology. 2015;149(5):1275-1285.e2. doi: 10.1053/j.gastro.2015.07.003 - DOI - PubMed
    1. De Las Heras Páez De La Cadena B, Martín Algíbez A, Martín Algíbez A.. Use of contrast-enhanced ultrasound for chronic inflammatory bowel disease. Rev Esp Enfermedades Dig. 2021;113(4):286-291. doi:10.17235/reed.2020.7499/2020 - DOI - PubMed
    1. Pecere S, Holleran G, Ainora ME, et al. . Usefulness of contrast-enhanced ultrasound (CEUS) in Inflammatory Bowel Disease (IBD). Dig Liver Dis. 2018;50(8):761-767. doi: 10.1016/j.dld.2018.03.023 - DOI - PubMed

LinkOut - more resources